Advances in the Management of Psoriasis
Learn about the latest treatments for plaque psoriasis, their evidence, and patient counseling points. Stay up-to-date to provide the best care.
About this course
With the recent FDA approval of several interleukin-23 antagonists added to the list of biologic response modifiers used in the management of plaque psoriasis, healthcare professionals need to be up-to-date with treatment options for this disease, evidence supporting their use, and patient-specific counseling points for psoriasis medications. Healthcare professionals completing this continuing education program will learn about the underlying pathophysiology of plaque psoriasis, pharmacotherapy options to treat mild, moderate, and severe psoriasis, and how to select the best treatment option for patients based on history, comorbidities, and disease severity.
Course Accreditation
This course is approved for the following professions. You can get more details on each profession by clicking on it.
Faculty
InstructorsYou might also be interested in
What are others saying?
Take a look at what other healthcare professionals are saying about AchieveCE’s continuing education courses.
Requirements
Participants must score a passing grade of 70% or higher on the activity post-test and complete an activity evaluation. There are no time limits and unlimited test-taking attempts. Credits will be reported automatically to CE Broker if your license information is entered properly in your profile.
- Windows 8.1
- Windows 10
- Mac OS X 10.1+
- iOS 10+
- Android 4.3+
- Google Chrome
- Microsft Edge
- Mozilla Firefox
- Adobe Acrobat Reader
- Broadband Internet Connection: T1
- Hi-speed DSL or Cable4G cellular connection